ineffective drugs
12/10/2017
/
By Michelle Simmons
Diabetes drug manufacturers unable to prove any real benefit to patients
Manufacturers of diabetes drugs could not prove any real additional benefit of sitagliptin to individuals with diabetes, according to a report by the Institute for Quality and Efficiency in Health Care (IQWiG). The IQWiG reevaluated the effects of the diabetes drug known as sitagliptin compared to the appropriate comparator therapies for diabetic people. Sitagliptin, which […]
« Return Home
1 of 1
Popular Articles
COPYRIGHT © 2017 BIG PHARMA NEWS
Privacy Policy